251 related articles for article (PubMed ID: 20380657)
1. Metformin induces glucose uptake in human preadipocyte-derived adipocytes from various fat depots.
Fischer M; Timper K; Radimerski T; Dembinski K; Frey DM; Zulewski H; Keller U; Müller B; Christ-Crain M; Grisouard J
Diabetes Obes Metab; 2010 Apr; 12(4):356-9. PubMed ID: 20380657
[TBL] [Abstract][Full Text] [Related]
2. Low-abundant adiponectin receptors in visceral adipose tissue of humans and rats are further reduced in diabetic animals.
Bauer S; Weigert J; Neumeier M; Wanninger J; Schäffler A; Luchner A; Schnitzbauer AA; Aslanidis C; Buechler C
Arch Med Res; 2010 Feb; 41(2):75-82. PubMed ID: 20470935
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance induced by high glucose and high insulin precedes insulin receptor substrate 1 protein depletion in human adipocytes.
Renström F; Burén J; Svensson M; Eriksson JW
Metabolism; 2007 Feb; 56(2):190-8. PubMed ID: 17224332
[TBL] [Abstract][Full Text] [Related]
4. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women.
Drolet R; Bélanger C; Fortier M; Huot C; Mailloux J; Légaré D; Tchernof A
Obesity (Silver Spring); 2009 Mar; 17(3):424-30. PubMed ID: 19219061
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of metformin action on glucose transport and metabolism in human adipocytes.
Grisouard J; Timper K; Radimerski TM; Frey DM; Peterli R; Kola B; Korbonits M; Herrmann P; Krähenbühl S; Zulewski H; Keller U; Müller B; Christ-Crain M
Biochem Pharmacol; 2010 Dec; 80(11):1736-45. PubMed ID: 20816671
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects.
Walker GE; Marzullo P; Verti B; Guzzaloni G; Maestrini S; Zurleni F; Liuzzi A; Di Blasio AM
Obesity (Silver Spring); 2008 Sep; 16(9):1983-91. PubMed ID: 19186324
[TBL] [Abstract][Full Text] [Related]
7. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
8. Glucose uptake and insulin action in human adipose tissue--influence of BMI, anatomical depot and body fat distribution.
Stolic M; Russell A; Hutley L; Fielding G; Hay J; MacDonald G; Whitehead J; Prins J
Int J Obes Relat Metab Disord; 2002 Jan; 26(1):17-23. PubMed ID: 11791142
[TBL] [Abstract][Full Text] [Related]
9. Effects of metformin and vanadium on leptin secretion from cultured rat adipocytes.
Mueller WM; Stanhope KL; Gregoire F; Evans JL; Havel PJ
Obes Res; 2000 Oct; 8(7):530-9. PubMed ID: 11068959
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
[TBL] [Abstract][Full Text] [Related]
11. The relationship between fat depot-specific preadipocyte differentiation and metabolic syndrome in obese women.
Park HT; Lee ES; Cheon YP; Lee DR; Yang KS; Kim YT; Hur JY; Kim SH; Lee KW; Kim T
Clin Endocrinol (Oxf); 2012 Jan; 76(1):59-66. PubMed ID: 21711372
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 release from human abdominal adipose cells is regulated by thyroid-stimulating hormone: effect of adipocyte differentiation and anatomic depot.
Antunes TT; Gagnon A; Chen B; Pacini F; Smith TJ; Sorisky A
Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1140-4. PubMed ID: 16682487
[TBL] [Abstract][Full Text] [Related]
13. Effects of metformin and oleic acid on adipocyte expression of resistin.
Rea R; Donnelly R
Diabetes Obes Metab; 2006 Jan; 8(1):105-9. PubMed ID: 16367888
[TBL] [Abstract][Full Text] [Related]
14. Metformin restores responses to insulin but not to growth hormone in Sprague-Dawley rats.
Borst SE; Snellen HG; Ross H; Scarpace PJ; Kim YW
Biochem Biophys Res Commun; 2002 Mar; 291(3):722-6. PubMed ID: 11855850
[TBL] [Abstract][Full Text] [Related]
15. Depot-specific effects of early growth retardation on adipocyte insulin action.
Ozanne SE; Dorling MW; Wang CL; Petry CJ
Horm Metab Res; 2000 Feb; 32(2):71-5. PubMed ID: 10741689
[TBL] [Abstract][Full Text] [Related]
16. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway.
Zierath JR; Livingston JN; Thörne A; Bolinder J; Reynisdottir S; Lönnqvist F; Arner P
Diabetologia; 1998 Nov; 41(11):1343-54. PubMed ID: 9833943
[TBL] [Abstract][Full Text] [Related]
17. Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women.
Corbould A
J Endocrinol; 2007 Mar; 192(3):585-94. PubMed ID: 17332526
[TBL] [Abstract][Full Text] [Related]
18. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM
Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
[TBL] [Abstract][Full Text] [Related]
19. Deep subcutaneous adipose tissue: a distinct abdominal adipose depot.
Walker GE; Verti B; Marzullo P; Savia G; Mencarelli M; Zurleni F; Liuzzi A; Di Blasio AM
Obesity (Silver Spring); 2007 Aug; 15(8):1933-43. PubMed ID: 17712110
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous and visceral adipose tissue: structural and functional differences.
Ibrahim MM
Obes Rev; 2010 Jan; 11(1):11-8. PubMed ID: 19656312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
